TM4SF5 and metabolic dysfunction-associated steatohepatitis: Indeed, suppression of the TM4SF5 downstream effector CCL20 leads to the blockade of HFD-mediated NASH phenotypes,23 and Tm4sf5−/− KO mice show protection from diet-induced obesity.34